Regarding virus infections, it has been shown that by using transgenic mouse models and adenoviral HBV expression, iNKT cell activation is achieved through α-GalCer administration, which is capable of promoting systemic IFN-γ production together with IFN-α/β that inhibits viral replication [144]. The gene discussed is IFNG; the disease is viral infectious disease.